Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 10673 matches for

The Department of Oncology is pleased to announce that Professor Amato J Giaccia has been appointed as the new Director of the MRC Oxford Institute for Radiation Oncology (OIRO).

Professor Amato Giaccia

DPhil Projects for 2025-26 Entry

UKHSA project: Investigating the efficacy of ultra-high dose rates of ionizing radiation (FLASH radiotherapy) in reducing radiation toxicity during radiotherapy

Contact Us

EMERALD Pancreas: Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer

Student Interviews

60 seconds with...

Welcome

The Department of Oncology's mission is to improve cancer care through research and teaching. There is strong emphasis on translation, with established infrastructure to develop scientific insights toward clinical appreciation.

Course Overview

The MSc in Radiobiology is scheduled to run over one academic year as a full-time course consisting of eight compulsory taught modules and a research-based dissertation.

ARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC

CEDAR: Chemoradiation with Enadenotucirev as a radiosensitiser in locally Advanced Rectal cancer

IpiGlio: A Phase II, Open Label, Randomised Study of Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma

LungVax

LungVax: A Phase I Dose-escalation and Phase II Precision-Prevention trial of ChAdOx2-lungvax-NYESO vaccination for patients at risk of new or recurrent non-small cell lung cancer (NSCLC

OCTOVA: Paclitaxel, olaparib and cediranib in platinum-resistant ovarian cancer.

Advancing CLL Management

This is a continuing professional development course promoting state of the art Chronic Lymphocytic Leukaemia diagnosis, management, and clinical research globally. This course is run in partnership with the International Workshop on Chronic Lymphocytic Leukemia (iwCLL).

PanDox : Feasibility of Enhanced Chemotherapy Delivery to non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused Ultrasound

Introductory Physics for Radiobiology

Human Anatomy for Medical Physics

Short Courses

Underpinning Biology for Cancer Science

Hudson Alakonya - DPhil in Oncology

Hudson Alakonya shares his experience as a DPhil in Oncology student at the Department of Oncology.

Load More

Similar stories

New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Machine Learning Enhances Detection of Multiple Cancer Types from Blood

Researchers from the University of Oxford have developed TriOx, a highly sensitive blood test that detects six cancers at their earliest stages. Published today in Nature Communications, the findings highlight the test’s potential to transform early cancer detection and improve patient outcomes.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.